Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 36611 | 9.6 |
09:34 ET | 2067 | 9.65 |
09:39 ET | 1400 | 9.66 |
09:41 ET | 911 | 9.695 |
09:43 ET | 919 | 9.72 |
09:45 ET | 2000 | 9.755 |
09:48 ET | 1966 | 9.81 |
09:50 ET | 1327 | 9.8 |
09:52 ET | 981 | 9.77 |
09:54 ET | 1300 | 9.785 |
09:56 ET | 1035 | 9.81 |
09:57 ET | 4300 | 9.835 |
09:59 ET | 610 | 9.83 |
10:01 ET | 10926 | 9.835 |
10:03 ET | 7981 | 9.86 |
10:06 ET | 1601 | 9.86 |
10:08 ET | 1000 | 9.9 |
10:10 ET | 701 | 9.93 |
10:12 ET | 150 | 9.92 |
10:14 ET | 2006 | 9.95 |
10:15 ET | 3141 | 9.955 |
10:17 ET | 5996 | 10.01 |
10:19 ET | 200 | 10.02 |
10:21 ET | 1860 | 10.02 |
10:24 ET | 2000 | 10.006 |
10:26 ET | 900 | 9.99 |
10:28 ET | 598 | 9.9976 |
10:30 ET | 1700 | 9.995 |
10:32 ET | 3400 | 9.965 |
10:33 ET | 400 | 9.965 |
10:35 ET | 900 | 9.965 |
10:37 ET | 12261 | 10 |
10:39 ET | 2202 | 10 |
10:42 ET | 700 | 9.995 |
10:44 ET | 1300 | 9.98 |
10:46 ET | 400 | 9.98 |
10:48 ET | 1100 | 9.975 |
10:50 ET | 377 | 9.98 |
10:51 ET | 2900 | 10.01 |
10:53 ET | 600 | 10.02 |
10:55 ET | 100 | 10.0299 |
10:57 ET | 1000 | 10.02 |
11:00 ET | 5188 | 10.0016 |
11:02 ET | 7707 | 9.97 |
11:04 ET | 100 | 9.96 |
11:06 ET | 200 | 9.96 |
11:09 ET | 1700 | 9.99 |
11:13 ET | 400 | 9.99 |
11:15 ET | 100 | 9.99 |
11:18 ET | 1301 | 9.99 |
11:20 ET | 585 | 9.99 |
11:22 ET | 100 | 9.99 |
11:24 ET | 4800 | 9.99 |
11:26 ET | 500 | 10 |
11:27 ET | 1388 | 10.03 |
11:29 ET | 701 | 10.05 |
11:31 ET | 900 | 10.06 |
11:33 ET | 8866 | 10.099 |
11:36 ET | 790 | 10.0999 |
11:38 ET | 500 | 10.1 |
11:40 ET | 1459 | 10.14 |
11:42 ET | 7518 | 10.1559 |
11:44 ET | 798 | 10.2 |
11:45 ET | 1450 | 10.2 |
11:47 ET | 500 | 10.195 |
11:49 ET | 8245 | 10.225 |
11:51 ET | 1897 | 10.2199 |
11:54 ET | 400 | 10.2299 |
11:56 ET | 400 | 10.21 |
11:58 ET | 100 | 10.21 |
12:00 ET | 2119 | 10.185 |
12:02 ET | 3900 | 10.1405 |
12:03 ET | 1088 | 10.15 |
12:05 ET | 3594 | 10.19 |
12:07 ET | 701 | 10.175 |
12:09 ET | 200 | 10.19 |
12:12 ET | 250 | 10.2 |
12:14 ET | 400 | 10.18 |
12:16 ET | 700 | 10.155 |
12:18 ET | 200 | 10.16 |
12:20 ET | 412 | 10.16 |
12:21 ET | 19692 | 10.19 |
12:23 ET | 500 | 10.19 |
12:25 ET | 1402 | 10.185 |
12:27 ET | 1716 | 10.19 |
12:30 ET | 100 | 10.205 |
12:32 ET | 1311 | 10.18 |
12:34 ET | 580 | 10.18 |
12:36 ET | 700 | 10.19 |
12:39 ET | 312 | 10.19 |
12:41 ET | 700 | 10.195 |
12:43 ET | 100 | 10.195 |
12:45 ET | 225 | 10.195 |
12:48 ET | 2523 | 10.2 |
12:50 ET | 300 | 10.2 |
12:52 ET | 623 | 10.22 |
12:54 ET | 1904 | 10.21 |
12:56 ET | 1179 | 10.205 |
12:57 ET | 200 | 10.205 |
12:59 ET | 7519 | 10.2601 |
01:01 ET | 479 | 10.24 |
01:03 ET | 320 | 10.22 |
01:06 ET | 400 | 10.215 |
01:08 ET | 1207 | 10.24 |
01:10 ET | 300 | 10.24 |
01:12 ET | 1149 | 10.235 |
01:14 ET | 1004 | 10.235 |
01:15 ET | 600 | 10.23 |
01:17 ET | 300 | 10.23 |
01:19 ET | 1662 | 10.23 |
01:21 ET | 1388 | 10.24 |
01:24 ET | 100 | 10.24 |
01:26 ET | 8032 | 10.24 |
01:28 ET | 2995 | 10.27 |
01:30 ET | 1100 | 10.265 |
01:32 ET | 2596 | 10.27 |
01:33 ET | 612 | 10.2899 |
01:35 ET | 300 | 10.28 |
01:37 ET | 2032 | 10.27 |
01:39 ET | 949 | 10.27 |
01:42 ET | 716 | 10.27 |
01:44 ET | 11070 | 10.2896 |
01:46 ET | 11671 | 10.25 |
01:48 ET | 1270 | 10.24 |
01:50 ET | 1708 | 10.2 |
01:51 ET | 1600 | 10.2 |
01:53 ET | 600 | 10.215 |
01:55 ET | 6200 | 10.18 |
01:57 ET | 930 | 10.18 |
02:00 ET | 1659 | 10.195 |
02:02 ET | 600 | 10.2 |
02:04 ET | 1805 | 10.19 |
02:06 ET | 7682 | 10.18 |
02:08 ET | 1420 | 10.1769 |
02:09 ET | 4187 | 10.19 |
02:13 ET | 4730 | 10.21 |
02:15 ET | 1165 | 10.234 |
02:18 ET | 2792 | 10.24 |
02:20 ET | 1084 | 10.23 |
02:24 ET | 496 | 10.23 |
02:27 ET | 1121 | 10.23 |
02:29 ET | 2541 | 10.225 |
02:31 ET | 3975 | 10.23 |
02:33 ET | 1036 | 10.225 |
02:36 ET | 1790 | 10.2201 |
02:38 ET | 6567 | 10.18 |
02:40 ET | 1359 | 10.18 |
02:42 ET | 1869 | 10.18 |
02:44 ET | 1396 | 10.18 |
02:45 ET | 661 | 10.18 |
02:47 ET | 718 | 10.18 |
02:49 ET | 560 | 10.18 |
02:51 ET | 9569 | 10.1801 |
02:54 ET | 8980 | 10.205 |
02:56 ET | 1500 | 10.205 |
02:58 ET | 5115 | 10.23 |
03:00 ET | 734 | 10.215 |
03:02 ET | 1780 | 10.215 |
03:03 ET | 5410 | 10.215 |
03:05 ET | 1346 | 10.215 |
03:07 ET | 600 | 10.2181 |
03:09 ET | 7598 | 10.235 |
03:12 ET | 14529 | 10.235 |
03:14 ET | 4223 | 10.26 |
03:16 ET | 400 | 10.255 |
03:18 ET | 6681 | 10.29 |
03:20 ET | 935 | 10.275 |
03:21 ET | 1727 | 10.28 |
03:23 ET | 1500 | 10.28 |
03:25 ET | 600 | 10.28 |
03:27 ET | 17141 | 10.26 |
03:30 ET | 4646 | 10.265 |
03:32 ET | 5487 | 10.28 |
03:34 ET | 11330 | 10.3 |
03:36 ET | 3494 | 10.325 |
03:38 ET | 2453 | 10.3299 |
03:39 ET | 9053 | 10.31 |
03:41 ET | 5589 | 10.275 |
03:43 ET | 3215 | 10.271 |
03:45 ET | 3617 | 10.265 |
03:48 ET | 3243 | 10.24 |
03:50 ET | 4026 | 10.205 |
03:52 ET | 6388 | 10.185 |
03:54 ET | 3769 | 10.19 |
03:56 ET | 11011 | 10.24 |
03:57 ET | 28078 | 10.195 |
03:59 ET | 150400 | 10.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.3B | -2.5x | --- |
Prothena Corporation PLC | 1.2B | -6.7x | --- |
Immatics NV | 1.1B | -10.0x | --- |
Gyre Therapeutics Inc | 1.2B | -7.0x | --- |
Silence Therapeutics PLC | 1.1B | -17.9x | --- |
Arcus Biosciences Inc | 1.5B | -5.6x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.51 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 17.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.